Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human PRKACG Stable Cell Line

    [CAT#: S01YF-1023-PY60]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX439 Magic™ Human PKACγ(PRKACG) in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;HeLa
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Bleeding Disorder, Platelet-Type, 19; Stormorken Syndrome
    Gene ID
    Human:5568
    UniProt ID
    Human:P22612

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    PRKACG, a gene involved in the cyclic AMP-dependent protein kinase A (PKA) pathway, has been implicated in various diseases and conditions. In coronary artery disease (CAD), the up-regulation of PRKACG is associated with higher levels of high-density lipoprotein cholesterol (HDL-C) and the efficiency of reverse cholesterol transport. In Alzheimer's disease (AD) and type 2 diabetes mellitus (DM), PRKACG is identified as one of the essential hub genes and may play a role in the shared pathophysiological mechanisms of these diseases. In breast cancer, low expression of PKA, which includes PRKACG, is associated with adverse patient survival, particularly in estrogen receptor-positive breast cancer. Overall, PRKACG has been identified as a potential target for the diagnosis and treatment of CAD, AD, DM, and breast cancer.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human PRKACG Stable Cell Line (S01YF-1023-PY60). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Skyler Garcia (Verified Customer)

    What is the role of PRKACG in platelet biogenesis? Aug 06 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    PRKACG is a central actor in platelet biogenesis, and mutations in this gene can lead to inherited thrombocytopenia with giant platelets. Aug 06 2021

    chat Jordan Garcia (Verified Customer)

    How is PRKACG linked to coronary artery disease? Aug 29 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    In coronary artery disease, PRKACG expression is a positive predictor of high-density lipoprotein cholesterol levels, impacting HDL functionality. Aug 29 2021

    Published Data

    Fig.1 Alterations in the subcellular localization of BACE1 and EEA1 were observed in HeLa cells following knockdown of the kinase.

    HeLa cells that had been grown on glass-based dishes were transfected with 50 nm siRNA against a control protein (eGFP), PRKACG, or GSK3β. The cells were further transfected with 1 µg/mL BACE1-myc plasmid at 48 h after transfection with the siRNAs. After further incubation for 24 h, the cells were fixed and dual-immunostained with anti-myc and anti-EEA1 antibodies, followed by Alexa 488- or Cy3-conjugated secondary antibodies, respectively. The samples were viewed using an LSM510 confocal microscope with a 63x Plan-Neofluar oil immersion objective. Scale bar = 10 µm.

    Ref: Adachi, Atsuhiro, et al. "Visual screening and analysis for kinase-regulated membrane trafficking pathways that are involved in extensive β-amyloid secretion." Genes to Cells 14.3 (2009): 355-369.

    Pubmed: 19210549

    DOI: 10.1111/j.1365-2443.2008.01274.x

    Research Highlights

    D Dergunov, Alexander. et al. "Differential Expression of Subsets of Genes Related to HDL Metabolism and Atherogenesis in the Peripheral Blood in Coronary Artery Disease." Current issues in molecular biology, 2023.
    In this study, researchers investigated the differential expression of genes (DEGs) in 76 male patients with coronary artery disease (CAD) and 63 control patients. They also explored the correlation between transcript level and high-density lipoprotein cholesterol (HDL-C). The transcript level of 24 genes related to HDL metabolism and 41 genes related to atherosclerosis-prone was measured using real-time RT-PCR on RNA extracted from peripheral blood mononuclear cells. A total of 28 DEGs were discovered, with upregulation of cholesterol transporters, lipoprotein metabolism genes, and inflammation-regulating genes observed in CAD patients.
    D Dergunov, Alexander. et al. "Differential Expression of Subsets of Genes Related to HDL Metabolism and Atherogenesis in the Peripheral Blood in Coronary Artery Disease." Current issues in molecular biology, 2023.
    Pubmed: 37623250   DOI: 10.3390/cimb45080431

    Ye, Xian-Wen. et al. "Exploring the common pathogenesis of Alzheimer's disease and type 2 diabetes mellitus via microarray data analysis" Frontiers in aging neuroscience, 2023.
    The incidence of Alzheimer's Disease (AD) and Type 2 Diabetes Mellitus (DM) is on the rise in contemporary society. However, despite mounting evidence linking DM to an increased risk of AD, the exact mechanisms underlying this relationship have yet to be fully understood. Further research is needed to elucidate the interrelationships between these two diseases.
    Ye, Xian-Wen. et al. "Exploring the common pathogenesis of Alzheimer's disease and type 2 diabetes mellitus via microarray data analysis" Frontiers in aging neuroscience, 2023.
    Pubmed: 36923118   DOI: 10.3389/fnagi.2023.1071391

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare